Solid Biosciences Incの将来のP / E
Solid Biosciences Incの将来のP / Eは何ですか。
Solid Biosciences Incの将来のP / Eは-0.58です。
将来のP / Eの定義は何ですか。
未来比率P / E (株価収益率)は、企業の株価と今後12ヶ月間の1株当たり利益見込額との比率です。
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
NASDAQのセクタHealth Careにおける将来のP / Eの企業と比べるSolid Biosciences Inc
Solid Biosciences Incは何をしますか。
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Solid Biosciences Incと類似の将来のp / e
- Checkpoint Therapeutics Incの将来のP / Eは-0.63です。
- Brainstorm Cell Therapeuticsの将来のP / Eは-0.62です。
- Fortress Biotech Incの将来のP / Eは-0.61です。
- Moleculin Biotech Incの将来のP / Eは-0.61です。
- Clean Diesel Technologiesの将来のP / Eは-0.60です。
- BeyondSpring Incの将来のP / Eは-0.59です。
- Solid Biosciences Incの将来のP / Eは-0.58です。
- Aethlon Medical Incの将来のP / Eは-0.57です。
- Petroteqの将来のP / Eは-0.57です。
- Kezar Life Sciences Incの将来のP / Eは-0.57です。
- Trevena Incの将来のP / Eは-0.57です。
- Seres Therapeutics Incの将来のP / Eは-0.57です。
- AwoX SAの将来のP / Eは-0.56です。